机构:[1]Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.[2]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.临床科室肿瘤免疫科河北医科大学第四医院[3]Department of Nuclear Medicine, The First Affiliated Hospital, College of Medicine, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou University, Jianshe East Road, Zhengzhou 450052, Henan, China.[4]Department of Medical Technology, Nanyang Medical College, 1106 Xuefeng West Road, Nanyang 473000, Henan, China.[5]Department of Nuclear Medicine, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, China.四川省人民医院[6]Department of Nuclear Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.[7]Department of Cardiology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.[8]Department of Breast and Thyroid Surgery, The Second People's Hospital of Lianyungang, Lianyungang, China.[9]Department of Radiology, Beijing Jingmei Group General Hospital, Beijing, China.
第一作者机构:[1]Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Qian Ruijie,Guo Yawen,Wang Ruihua,et al.Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation[J].Biomaterials Research.2024,28:0038.doi:10.34133/bmr.0038.
APA:
Qian Ruijie,Guo Yawen,Wang Ruihua,Wang Shuai,Gao Xuemei...&Han Xinwei.(2024).Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation.Biomaterials Research,28,
MLA:
Qian Ruijie,et al."Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation".Biomaterials Research 28.(2024):0038